• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,727.05 -516.29
( -0.70%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
20.82
14485.72
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.63
 

Thomas Cook (India) consolidated net profit declines 40.13% in the March 2026 quarter
May 13,2026
Net profit of Thomas Cook (India) declined 40.13% to Rs 38.66 crore in the quarter ended March 2026 as against Rs 64.57 crore during the previous quarter ended March 2025. Sales declined 10.07% to Rs 1770.69 crore in the quarter ended March 2026 as against Rs 1968.86 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.95% to Rs 218.85 crore in the year ended March 2026 as against Rs 254.33 crore during the previous year ended March 2025. Sales rose 3.18% to Rs 8398.17 crore in the year ended March 2026 as against Rs 8139.57 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1770.691968.86 -10 8398.178139.57 3
OPM %4.434.99 -5.095.86 -
PBDT90.07127.91 -30 492.36527.06 -7
PBT47.6591.55 -48 332.83385.18 -14
NP38.6664.57 -40 218.85254.33 -14